AbstractData from large patient samples evaluating the magnitude of benefit with the newer anti-fungal agents are lacking. We have analyzed the Nationwide Inpt Sample (NIS) database to evaluate the trends in the incidence of fungal infections and to evaluate the potential impact of newer anti-fungal agents on in-hospital mortality among allo-SCT recipients. Our data suggests that the use of newer anti-fungal agents has an impact on the survivability of fungal infections in the setting of allo-SCT.
Authors own copyright of their articles appearing in the Online Journal of Public Health Informatics. Readers may copy articles without permission of the copyright owner(s), as long as the author and OJPHI are acknowledged in the copy and the copy is used for educational, not-for-profit purposes. Share-alike: when posting copies or adaptations of the work, release the work under the same license as the original. For any other use of articles, please contact the copyright owner. The journal/publisher is not responsible for subsequent uses of the work, including uses infringing the above license. It is the author's responsibility to bring an infringement action if so desired by the author.